Founded Year



Acq - Pending | Acquired

Total Raised




About Akili Interactive Labs

Akili Interactive Labs is building clinically validated cognitive treatments and assessments that are delivered in an action video game interface. Leveraging medical-grade science and consumer-grade software technology, the company is seeking to produce a new type of medical product that can offer safe and effective scalable treatment and better patient monitoring for patients across a range of mental health and neurological conditions.

Akili Interactive Labs Headquarter Location

125 Broad Street 5th Floor

Boston, Massachusetts, 02110,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Akili Interactive Labs's Products & Differentiation

See Akili Interactive Labs's products and how their products differentiate from alternatives and competitors

  • EndeavorRx

    The EndeavorRx app is a digital treatment indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD who have a demonstrated attention issue and should be considered for use as part of a therapeutic program. EndeavorRx is an FDA-cleared medical device and must be prescribed by a healthcare professional. It is not intended as a stand-alone therapeutic, nor is it a substitute for a child’s medication.


    EndeavorRx is the only prescription video game available for the treatment of ADHD. 

Expert Collections containing Akili Interactive Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Akili Interactive Labs is included in 6 Expert Collections, including Digital Health.


Digital Health

13,489 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)


Mental Health Tech

1,215 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Medical Devices

12,028 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

15,795 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Health IT

7,900 items

Akili Interactive Labs Patents

Akili Interactive Labs has filed 22 patents.

The 3 most popular patent topics include:

  • Cognition
  • Cognitive tests
  • Psychiatric diagnosis
patents chart

Application Date

Grant Date


Related Topics




Cognitive biases, Physical exercise, Cognition, Cognitive tests, Educational psychology


Application Date


Grant Date



Related Topics

Cognitive biases, Physical exercise, Cognition, Cognitive tests, Educational psychology



Latest Akili Interactive Labs News

Franklin becomes president and COO at PureTech’s Akili

Jun 7, 2022

Franklin becomes president and COO at PureTech’s Akili Plus new CMOs at Artiva and Third Harmonic, and updates from Dotmatics By Richard Guy, Biopharma Analyst and Gunjan Ohri, Data Content Analyst June 7, 2022 12:01 AM UTC Akili Interactive Labs Inc. hired Matt Franklin in the newly created role of president and COO, effective June 21. Franklin was the general manager of precision oncology business unit at Exact ... Access this Article

Akili Interactive Labs Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Akili Interactive Labs Rank

  • When was Akili Interactive Labs founded?

    Akili Interactive Labs was founded in 2011.

  • Where is Akili Interactive Labs's headquarters?

    Akili Interactive Labs's headquarters is located at 125 Broad Street, Boston.

  • What is Akili Interactive Labs's latest funding round?

    Akili Interactive Labs's latest funding round is Acq - Pending.

  • How much did Akili Interactive Labs raise?

    Akili Interactive Labs raised a total of $270.4M.

  • Who are the investors of Akili Interactive Labs?

    Investors of Akili Interactive Labs include Social Capital Suvretta Holdings I, Jazz Venture Partners, Evidity Health Capital, Amgen Ventures, Baillie Gifford & Co. and 21 more.

  • Who are Akili Interactive Labs's competitors?

    Competitors of Akili Interactive Labs include Pear Therapeutics and 8 more.

  • What products does Akili Interactive Labs offer?

    Akili Interactive Labs's products include EndeavorRx.

You May Also Like

Pear Therapeutics Logo
Pear Therapeutics

Pear Therapeutics discovers, develops, and delivers clinically-validated Prescription Digital Therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effection solutions for payers.

Happify Logo

Happify is a LifeTech company that delivers digital therapeutics and care delivery models to improve mental and physical health. Happify Health’s safe, effective digital tools use scientific research from positive psychology, CBT, and mindfulness, combined with a gamified approach and technology, to impact everyday lives. Happify Health's clinically-validated platform provides global access to a comprehensive, evidence-based intervention catalog.

Limbix Logo

Limbix makes virtual reality and digital treatment tools for therapists.

Click Therapeutics Logo
Click Therapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. Click's smoking cessation program is currently available nationwide through a variety of payers, providers, and employers. Click Therapeutics was founded in 2012 and is based in New York, New York.

Cognoa Logo

Cognoa’s AI-driven products enable early intervention of behavioral health conditions to improve lifelong outcomes. The firm develops prescription digital therapeutics for the earlier identification and treatment of behavioral health conditions in order to change the standard of care and improve lifelong outcomes for children.


Elemy is a provider of in-home and online pediatric behavioral care, including pediatric autism.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.